VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor

被引:91
作者
Wu, LW
Mayo, LD
Dunbar, JD
Kessler, KM
Ozes, ON
Warren, RS
Donner, DB
机构
[1] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[3] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.275.9.6059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A protein that binds the intracellular domain of KDR (KDR-IC), a receptor for vascular endothelial cell growth factor (VEGF), was identified by two-hybrid screening. Two-hybrid mapping showed that the VEGF receptor-associated protein (VRAP) interacted with tyrosine 951 in the kinase insert domain of HDR, Northern blot analysis identified multiple VRAP transcripts in peripheral leukocytes, spleen, thymus, heart, lung, and human umbilical vein endothelial cells (HUVEC). The predominant VRAP mRNA encodes a 389-amino acid protein that contains an SH2 domain and a C-terminal proline-rich motif. In HUVEC, VEGF promotes association of VRAP with KDR, Phospholipase C gamma and phosphatidylinositol S-kinase, effector proteins that are downstream of KDR and important to VEGF-induced endothelial cell survival and proliferative responses, associate constitutively with VRAP. These observations identify VRAP as an adaptor that recruits cytoplasmic signaling proteins to KDR, which plays an important role in normal and pathological angiogenesis.
引用
收藏
页码:6059 / 6062
页数:4
相关论文
共 30 条
[1]   VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J].
BERSE, B ;
BROWN, LF ;
VANDEWATER, L ;
DVORAK, HF ;
SENGER, DR .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) :211-220
[2]  
BREIER G, 1992, DEVELOPMENT, V114, P521
[3]  
Choi K, 1998, DEVELOPMENT, V125, P725
[4]   TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS [J].
CONNOLLY, DT ;
HEUVELMAN, DM ;
NELSON, R ;
OLANDER, JV ;
EPPLEY, BL ;
DELFINO, JJ ;
SIEGEL, NR ;
LEIMGRUBER, RM ;
FEDER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1470-1478
[5]   Interactions of FLT-1 and KDR with phospholipase C gamma: Identification of the phosphotyrosine binding sites [J].
Cunningham, SA ;
Arrate, MP ;
Brock, TA ;
Waxham, MN .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (03) :635-639
[6]  
DEVRIES C, 1992, SCIENCE, V255, P939
[7]   BIOLOGICAL-ACTIVITY AND PHOSPHORYLATION SITES OF THE BACTERIALLY EXPRESSED CYTOSOLIC DOMAIN OF THE KDR VEGF-RECEPTOR [J].
DOUGHERVERMAZEN, M ;
HULMES, JD ;
BOHLEN, P ;
TERMAN, BI .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (01) :728-738
[8]   Role of vascular endothelial growth factor in the regulation of angiogenesis [J].
Ferrara, N .
KIDNEY INTERNATIONAL, 1999, 56 (03) :794-814
[9]   Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase Akt signal transduction pathway -: Requirement for Flk-1/KDR activation [J].
Gerber, HP ;
McMurtrey, A ;
Kowalski, J ;
Yan, MH ;
Keyt, BA ;
Dixit, V ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) :30336-30343
[10]   VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR PROMOTES TYROSINE PHOSPHORYLATION OF MEDIATORS OF SIGNAL-TRANSDUCTION THAT CONTAIN SH2 DOMAINS - ASSOCIATION WITH ENDOTHELIAL-CELL PROLIFERATION [J].
GUO, DQ ;
JIA, Q ;
SONG, HY ;
WARREN, RS ;
DONNER, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) :6729-6733